EUVIMEDEUVIMED entdecken
Open Access

Cerbb-2/her-2 neu overexpression and prognostic significance in uterine carcinosarcoma

Huseyin Salih Semiz, Emel Ebru Pala, Behzat Can, Elif Atag, Hatice Gungor, Muzaffer Sanci

Turkish Journal of Pathology · 2022

DOI: 10.5146/tjpath.2022.01588 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Turkish Journal of Pathology, 2022. Verfasst von Huseyin Salih Semiz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Dokuz Eylül University Institute of Oncology, IZMIR, TURKEY. Hauptthemen laut MEDLINE: Carcinosarcoma, Uterine Neoplasms. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: There is not enough data in the literature regarding Her-2 overexpression in uterine carcinosarcomas or its association with the prognosis. The aim of this study was to determine the Her-2 overexpression rate in uterine carcinosarcoma and to evaluate its relationship with the prognosis. MATERIAL AND METHOD: Her-2 protein and gene status were evaluated by immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH), respectively, in hysterectomy specimens from 51 patients with uterine carcinosarcoma. RESULTS: Her-2 protein expression in the epithelial component was negative in 42 patients (score 0 in 33 cases, score (+1) in 9 cases), score (+2) in 7 patients and score (+3) in 2 patients. None of the patients had Her-2 protein expression within the sarcomatous component of the tumors. Her-2 gene was not amplified in epithelial or mesenchymal tumor areas according to the FISH method. There was no difference between the Her-2 overexpression negative and positive groups in terms of disease-free survival (DFS) and overall survival (OS). Her-2 overexpression was significantly higher in tumors of patients diagnosed at 65 years or older (p=0.046). CONCLUSION: In our study, no relationship could be shown between Her-2 overexpression and prognosis in uterine carcinosarcoma. More comprehensive studies are needed to illustrate the relationship between Her-2 overexpression and carcinosarcoma prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarcinosarcomaUterine NeoplasmsFemaleHumansPrognosisIn Situ Hybridization, FluorescenceErb-b2 Receptor Tyrosine KinasesImmunohistochemistryGene Amplification

Substanzen

Erb-b2 Receptor Tyrosine Kinases

Autor:innen und Institutionen

  • Department of Medical Oncology, Dokuz Eylül University Institute of Oncology, IZMIR, TURKEY.

Zitieren

APA

Semiz, H. S., Pala, E. E., Can, B., Atag, E., Gungor, H., & Sanci, M. (2022). Cerbb-2/her-2 neu overexpression and prognostic significance in uterine carcinosarcoma. Turkish Journal of Pathology. https://doi.org/10.5146/tjpath.2022.01588

Vancouver

Semiz HS, Pala EE, Can B, Atag E, Gungor H, Sanci M. Cerbb-2/her-2 neu overexpression and prognostic significance in uterine carcinosarcoma. Turkish Journal of Pathology. 2022. doi:10.5146/tjpath.2022.01588

BibTeX
@article{Semiz2022,
  author = {Semiz, Huseyin Salih and Pala, Emel Ebru and Can, Behzat and Atag, Elif and Gungor, Hatice and Sanci, Muzaffer},
  title = {Cerbb-2/her-2 neu overexpression and prognostic significance in uterine carcinosarcoma},
  journal = {Turkish Journal of Pathology},
  year = {2022},
  doi = {10.5146/tjpath.2022.01588}
}
Kostenlos starten →